Elucidating the role of gut microbes in CVD may provide future therapeutic strategiesApr. 1, 2016 - VBWG Meeting at ACC 2016, Chicago, IL, USA - Stanley L. Hazen, MD, PhD - Cleveland Clinical Foundation, Cleveland, OH, USA
Stanley Hazen discusses the connection between our gut microbiome and physiologic processes relevant to heart disease, via a pathway involving the metabolite TMAO. Diet and therapies can affect TMAO levels, which influences platelet reactivity. Specifically targeting microbes that increase TMAO levels, may prove to be a future therapeutic strategy.
Vascular Biology Working Group Meeting at ACC 2016, Chicago, IL, USA
Faculty & Disclosures
Stanley L. Hazen, MD, PhD - Cleveland Clinical Foundation, Cleveland, OH, USA